Trial Profile
A multicenter, randomized, double-blind, placebo-controlled, intraindividual-comparison phase IIa trial to evaluate the efficacy and safety of 2% AVT-02 UE ointment in the treatment of mild to moderate psoriasis vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Oct 2013
Price :
$35
*
At a glance
- Drugs AVT 02 (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Sponsors DOLTHERA
- 25 Jul 2012 New trial record